Xeljanz

Tofacitinib Citrate

9.9 High risk

There is an ongoing mass lawsuit against this drug.

If you have experienced any negative side effects, you could qualify for compensation.

Xeljanz & Drug ineffective

4.9%

of users reported Drug ineffective

81.6%

also reported Severe reaction

75.7%

are women

Most common medical consequences

Severe reaction
81.6%
Hospitalization
12.8%
Disability
3.3%
Death
2.3%

Have you experienced any negative side effects from this medication?

Xeljanz: general information

Most common side effects (795)

Most commonly affected ages

0 - 9 years
0.1%
10 - 19 years
1.4%
20 - 29 years
3.3%
30 - 39 years
5.0%
40 - 49 years
13.7%
50 - 59 years
23.8%
60 - 69 years
29.4%
70 - 79 years
18.0%
80 - 89 years
5.0%
90 - 99 years
0.3%
On this page
Xeljanz & Drug ineffective
Xeljanz: general information